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Abstract
Objectives To evaluate diffusion-weighted imaging (DWI) 
and diffusion kurtosis imaging (DKI) in the differentiation 
and characterisation of breast lesions.
Methods Thirty-six women underwent breast magnetic reso-
nance imaging (MRI) including a DWI sequence with multi-
ple b-values (50–3,000 s/mm2). Mean values for apparent 
diffusion coefficient (ADC), mean diffusivity (MD) and mean 
kurtosis (MK) were calculated by lesion type and histological 
subtype. Differences and correlation between parameters were 
determined.
Results Forty-four lesions were found. There were significant 
differences between benign and malignant lesions for all 
parameters (ADC, p=0.017; MD,  p=0.028; MK,  p=0.017).  
ADC and MD were higher for benign (1.96±0.41×10−3 and 
2.17±0.42×10−3 mm2/s, respectively) than for malignant
lesions (1.33±0.18×10−3 and 1.52±0.50×10−3 mm2/s). MK
was higher for malignant (0.61±0.27) than benign lesions
(0.37±0.18). We found differences between invasive ductal
carcinoma (IDC) and fibroadenoma (FA) for all parameters
(ADC,MD andMK): p=0.016, 0.022 and 0.016, respectively.
FA and fibrocystic change (FC) showed differences only in
MK (p=0.016).
Conclusions Diffusion in breast lesions follows a non-
Gaussian distribution. MK enables differentiation and
characterisation of breast lesions, providing new insights
into microstructural complexity. To confirm these re-
sults, further investigation in a broader sample should
be performed.
Key Points
• The diffusion kurtosis model provides new information re-
garding breast lesions
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• MD and MK are valid parameters to characterise tissue
microstructure
• MK enables improved lesion differentiation
• MK is able to differentiate lesions that display similar ADC
values
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DWI Diffusion-weighted imaging
ADC Apparent diffusion coefficient
PDF Probability of displacement function
DKI Diffusion kurtosis imaging
MD Mean diffusivity
MK Mean kurtosis
IDC Invasive ductal carcinoma
ILC Invasive lobular carcinoma
Introduction
Diffusion-weighted imaging (DWI) in breast imaging is a
widespread tool used in the differential diagnosis of breast
lesions [1–6]. When applying DWI to breast lesions, a mono-
exponential model is used to fit signal intensity (SI) decay
between two or more b-values and quantify the apparent
diffusion coefficient (ADC):
ln SðbÞ½  ¼ ln Sð0Þ½ −bADC ð1Þ
where S(b) and S(0) are the signal intensity at the echo time for
different b-values and b the diffusion sensitising value. This
model is based on the assumption that the microenvironment
is homogeneous, and also that the probability displacement
function (PDF) describing the displacement of water mole-
cules associated with diffusion follows a Gaussian distribution
[7]. However, biological tissues present natural barriers (such
as cell membranes) and cellular compartments (such as organ-
elles) that constrain water motion [8], resulting in a PDF with
a more peaked profile when compared with that of a Gaussian
distribution. The kurtosis excess is an index which reflects the
peak of a distribution and can be used to quantify how much
the PDF deviates from the Gaussian shape. This deviation
reflects tissue microstructure complexity [9], with the kurtosis
parameters serving as an index for lesion characterisation.
A preliminary study developed by our group focused on
the usefulness of performing visual lesion assessment using
large b-values (2,000 and 3,000) s/mm2 has confirmed that SI
attenuation when using higher b-values was no longer
described by a mono-exponential fitting. Nonetheless, in the
clinical setting, only the mono-exponential fitting is used on
MR, which conditions ADC quantification when higher b-
values are used [10].
Jensen et al. [9] first introduced the diffusion kurtosis
imaging (DKI) model. DKI is an extension of conventional
DWI, which accounts for non-Gaussian PDF distribution,
therefore further reflecting tissue complexity [9]. DKI requires
the use of high b-values to observe the non-Gaussian behav-
iour of water diffusion [11].
To obtain the kurtosis diffusional parameters, a fit is per-
formed with the signal decay modelled by the equation [9]:
ln SðbÞ½  ¼ ln Sð0Þ½ −bMDþ 1
6
b2MD2 MK þ O b3  ð2Þ
where MD is the mean diffusivity, MK is the mean kurtosis
and O(b3) is the fit error associated to the measurement. Both
parameter estimates reflect diffusion along the direction of the
diffusion sensitising gradients.
The MK parameter is a dimensionless metric. Comparing
Eqs. 1 and 2, it becomes clear that when MK is equal to zero,
MD becomes equal to ADC, and the PDF follows a Gaussian
distribution. A positive MK corresponds to a more peaked
PDF, which explains why lesions with a more complex mi-
crostructure display higher MK values [12].
Studies concerning DKI were developed in animal models,
brain, lungs, prostate and squamous cell carcinoma [13–18]
but, to the best of our knowledge, there is a lack of published
studies regarding the application of DKI in breast [19].
Adding MK may potentially result in higher sensitivity to
pathological tissue changes. Thus, our goal was to assess the
role of DWI and DKI models to differentiate and characterise
breast lesions.
Materials and methods
Subjects
This prospective study was included in a wider investigation,
and received approval from the Institutional Review Board
(CES 276/13). Written informed consent was obtained from
all patients.
Clinical indication for breast magnetic resonance imaging
(MRI) included women with: BRCA mutation (5), suspicious
lesions (17), identification of occult carcinoma (4), detection
of residual carcinoma (2), pre-operative evaluation (10), post-
surgery follow-up (3) and evaluation of breast implants (2).
Exclusion criteria to DWIwere applied to womenwho: had
been submitted to breast surgery, radiotherapy and/or chemo-
therapy within the previous 48 months (5); had cystic lesions
and/or breast implants (2); presented an undetectable
enhancing lesion on dynamic contrast-enhanced (DCE) im-
ages. The final sample included 36 women.
Acquisition protocol
MRI examinations were performed using a 3-T system (Tim
Trio; Siemens, Erlangen, Germany) and a four-channel bilat-
eral breast coil. Patients were positioned in the prone position.
The acquisition protocol included morphological se-
quences: axial bilateral T2-weighted (T2w) fast spin echo
(FSE), sagittal unilateral T1w three-dimensional (3D) gradient
echo (GRE) fast low angle shot (FLASH) and sagittal unilat-
eral T2w FSE with short tau inversion recovery (STIR). A
conventional DWI unilateral sagittal single-shot spin-echo
echo planar imaging (SS-SE-EPI) sequence with eight b-
values was performed before gadolinium injection, with gra-
dients sensitisation applied in the x, y and z directions to
generate three-scan-trace images. This sequence included a
larger number and higher b-values than typically used in the
clinical practice. The inclusion of the b-values 2,000 and
3,000 s/mm2 resulted in a TE of 106 ms. Finally, DCE axial
images were acquired during six phases with gadolinium
injection followed by unilateral sagittal fat-suppressed (water
exCitation) T1w 3D FLASH images. Protocol details are
shown in Table 1.
Image analysis
The imaging device workstation (Siemens Medical Systems,
with a work in progress version 17A) was used for image
analysis. Firstly, a radiologist (J.L.) with 6 years experience in
breast-imaging reported the conventional MRI images using
the Breast Imaging Reporting and Data System (BI-RADS)-
MRI lexicon [20] for lesion classification.
DWI datasets were analysed in consensus by two radiology
researchers. Each lesion was observed in the DW images
based on the MRI report, and using the T2w, DCE and the
post-contrast images, serving as a roadmap for regions of
interest (ROIs) demarcation. Firstly, ROIs demarcation were
performed for each lesion at b=400 s/mm2, and then copied to
the other b-values. This b-value was chosen due to the high
contrast between the lesion core and its outer limits. For each
lesion, a fixed size ROI (0.25 cm2) was drawn to include the
area of highest SI. The mean value and standard deviation
(SD) of the SI were recorded.
These SI values were fitted with two different models: a
mono-exponential function for the range b=50−1,000 s/mm2
(Eq. 1) and a DKI model using the higher b-values ranging
from 50 to 3,000 s/mm2 (Eq. 2) additionally. For this purpose,
an in-house script was developed in MATLAB software
(Mathworks, Cambridge, UK.) using the Levenberg-
Marquardt algorithm [19, 21]. The ADC, MD and MK were
then estimated for each lesion.
Statistical analysis
Mean values for each parameter were calculated for all le-
sions, by lesion type and histological subtype. Differences in
mean values were tested using the Mann-Whitney test. Cor-
relation between parameters was analysed by Spearman coef-
ficient (rS). PASW Statistics V17 software was used. Statisti-
cal significance was set at p<0.05.
Table 1 Scan protocol for conventional MRI and DWI pulse sequence
Parameters Conventional pre-contrast DWI-SPAIR Dynamic Post contrast
Sequence T2w TSE T1w 3D Flash T2w TSE Single-shot EPI T1w 3D Flash T1w 3D Flash
Orientation Axial Bilateral Sagittal Sagittal Sagittal Axial Bilateral Sagittal
TR/TE (ms) 4990/88 17/4.9 4920/67 4900/106 3.77/1.42 7.8/3.9
TI (ms) _ _ 210 _ _ _
Fat suppression _ _ STIR SPAIR SPAIR Water excitation
FOV (mm2) 320×320 200×200 200×200 250×250 320×320 160×160
Matrix 512×384 275×384 448×314 84×128 358×448 256×256
Slice thickness 4 2 4 5 0.9 0.9
Number of slices 26 64 26 16 160 144
NEX 2 1 2 3 1 1
Bandwidth (Hz/pixel) 305 430 248 1628 490 450
Scan time (min) 2:06 3:49 4:26 5:58 4:32 3:12
b-values (s/mm2) _ _ _ 50, 200, 400, 600, 800,
1000, 2000 and 3000
_ _
DWI-SPAIR diffusion-weighted imaging with spectrally adiabatic inversion recovery, TSE turbo spin echo, T1w 3D Flash three-dimensional gradient
echo fast low angle shot, EPI echo planar imaging, TR/TE repetition time/echo time, TI inversion time, STIR short tau inversion recovery, FOV field of
view, NEX number of excitations
Results
Patients and lesions characteristics
The final sample included 36 women with 44 lesions detected
in both the DCE and DWI. Histopathological proof was ob-
tained for 40 lesions. Malignant lesions were: ductal carcinoma
in situ (DCIS) (2); invasive ductal carcinoma (IDC) (19);
lobular carcinoma in situ (LCIS) (1); invasive lobular carcino-
ma (ILC) (9). Among benign lesions there were: fibroadenomas
(FAs) (7), epithelial proliferative lesion (EPL) (1), fibrocystic
change (FC) (1). Four additional lesions (1 FA and 3 FCs) were
assumed as benign, based on morphological features and di-
mensional stability as observed by a 2-year follow-up.
Figure 1 displays MR images of a 39-year-old woman with
a grade III invasive ductal carcinoma.
DWI and DKI: analysis of benign and malignant lesions
Table 2 presents mean values, derived from the mono-
exponential (ADC) and kurtosis models (MD and MK), by
lesion type.
There were significant differences for each of the parame-
ters between lesion types. Mean ADC and MD values were
higher in benign than in malignant lesions. Conversely, MK
was higher for malignant lesions than for benign ones.
Figure 2 represents the distribution of ADC (Fig. 2a), MD
(Fig. 2b) and MK (Fig. 2c) by lesion type, using the two
models.
Application of mono-exponential and kurtosis models,
by histological type
A descriptive analysis was performed for each model by
histological type (Table 3).
There were significant differences for ADC, MD and MK
between: IDC and FA (p=0.016, p=0.022 and p=0.016); IDC
and FC (p=0.003, p=0.004 and p=0.003), as well as between
ILC and FC (p=0.006, p=0.011 and p=0.034). For FA and
FC, only MK showed statistical difference (p=0.283, p=
0.386; and p=0.016).
Correlation between kurtosis parameters
Significant correlation was found between MD and MK for:
all the lesions rS=−0.636 (p<0.001), benign rS=−0.588 (p=
0.034) and malignant lesions rS=−0.546 (p<0.001).
Discussion
Breast pathological processes display large heterogeneity
[22]. It is also well known that lesions are not homogeneous,
even within the same histological type [23].
Fig. 1 A 39-year-old woman
with suspicious malignant lesion
in the upper left quadrant breast. a
Dynamic contrast-enhanced
acquisition image shows a mass
with irregular borders and
heterogeneous enhancement. b
Signal intensity/time curve
presents strong initially contrast
enhancement followed by
washout. c Sagittal post-contrast
T1w 3D GRE FLASH. d DWI
with a b-value of 1,000 s/mm2
image shows a hyperintense
lesion and e its respective mean
ADC map, where the lesion is
hypointense. Histological
diagnosis: invasive ductal
carcinoma, grade III
Table 2 Descriptive analysis of ADC, MD and MK using the two
models of DWI (mono-exponential and diffusion kurtosis), and differ-
ences by lesion type
Mean Benign (n=13) Malignant (n=31) p*
ADC a 1.96±0.41 1.33±0.43 0.017
MD a 2.17±0.42 1.52±0.50 0.028
MK b 0.37±0.18 0.61±0.27 0.017
ADC apparent diffusion coefficient, MD mean diffusivity, MK mean
kurtosis
a ADC and MD (×10−3 mm2 /s)
bMK is a dimensionless metric
*Statistical differences
In standard DWI, it is assumed that water diffusion PDF
follows a Gaussian distribution. However, complex microen-
vironment within tissues hampers water mobility and leads to
a diffusion PDF that probably does not follow a Gaussian
distribution [9]. Factors concurrent to the non-mono-
exponential diffusion behaviour include macromolecular
binding of water, restricted diffusion and water exchange
between multiple compartments [24–26].
In this study, significant differences between the ADC of
benign and malignant lesions were found when the mono-
exponential model was applied. Also, significant differences
were found for MD and MK between lesion types. This
feature means that MD andMK parameters could also be used
as valid parameters in lesion differentiation.
We found MK values lower for benign than for malignant
lesions, which means that the diffusion PDF of benign lesions
was less deviated from a Gaussian distribution, corresponding
to decreased restriction when compared to malignant lesions.
These differences were expected, considering that solid be-
nign lesions usually present lower microstructural complexity
than malignant tumours [27]. Moreover, the fact that both
benign and malignant lesions showed MK values greater than
zero strongly suggests that water PDFs differ from a Gaussian
distribution. This non-Gaussian behaviour is related to differ-
ent cellular compartments and the presence of lipid macro-
molecules [28].
In cancerous tissues, the increased cellularity usually leads
to more barriers within the tissues, which disturbs the regular
balance between the extra-cellular and cellular fractions, lead-
ing to higher restriction to water diffusion [29]. Still, the
movement of water molecules between compartments may
be more or less restricted depending on membrane permeabil-
ity [30]. A less cellular environment potentiates a larger extra-
cellular space and facilitates water motion [31].
In our study, the EPL lesion showed MK close to zero,
which suggests a decreased cellularity and a simple micro-
structure, closer to a homogeneous environment, without
Fig. 2 Box plots distribution of the parameters by lesion type using the
mono-exponential model ADC (a) and MD (b) and MK (c) using the
kurtosis model. MK is a dimensionless metric
Table 3 Descriptive analysis for mono-exponential and kurtosis model
by histological type
Histological
type
Mono-exponential Kurtosis
ADC (×10−3 mm2/s) MD (×10−3 mm2/s) MK a
DCIS (n=2) 1.31±0.43 1.50±0.50 0.33±0.47
IDC (n=19) 1.13±0.54 1.27±0.75 0.63±0.19
LCIS (n=1) 1.38 1.52 0.44
ILC (n=9) 1.43±0.45 1.62±0.51 0.63±0.38
FA (n=8) 1.82±0.44 2.08±0.52 0.48±0.09
EPL (n=1) 1.99 2.48 0
FC (n=4) 2.13±0.18 2.29±0.12 0.25±0.14
n number of lesions by histological type, DCIS ductal carcinoma in situ,
IDC invasive ductal carcinoma, LCIS lobular carcinoma in situ, ILC
invasive lobular carcinoma, FA fibroadenoma, EPL epithelial proliferative
lesion, FC fibrocystic change
aMK is a dimensionless metric
impediment of water distribution between spaces. IDC and
ILC evidenced highMK and lowMD, which can be explained
by their highly complex microstructures characteristic.
A study developed by Borlinhas et al. [19] presented sig-
nificant differences between MD and MK for IDC and FA.
They also observed that MD could distinguish IDC from
DCIS. In our study, we found differences in MK between
FA and FC, while ADC and MD could not differentiate them.
This may have quite a high impact for non-invasive differen-
tial diagnosis, especially because FA and FC sometimes pres-
ent overlapping ADCs within and with malignant lesions
depending on fibrolastic/miofibrolastic components. Howev-
er, given the low number of these type of lesions included in
this study, the results should be considered carefully.
Additionally, we found that MD and MK are not perfectly
monotonically related, i.e. MK contributes with additional
information other than MD.
Our study presents some limitations. Firstly, the number of
lesions is low for definitive conclusions. Secondly, the fact
that ten (four benign and six malignant) lesions were biopsied
before MRI could have influenced the measurements. Al-
though we have always performed MRI after a minimum
period of 8 days following biopsy, we cannot neglect that
residual blood and/or oedema could influence the parameters.
However, given the reduced number of cases, it was not
possible to assess the effect of biopsy on tissue structure.
Another limitation was the imaging time. The use of
the DKI model implies using higher b-values with in-
creased TE, prolonging the examination time. Despite
this inconvenience, our results suggested that MK could
help distinguish different grades of celullarity within the
same lesion group (FA vs FC). Given the wide spectrum
of breast lesions, even within the same histology group,
MK could play a role in such cases.
In conclusion, we have observed that ADC, MD and MK
can differentiate benign from malignant breast lesions. Fur-
thermore, our results suggest that the DKI model can help
characterise the complex behaviour of water diffusion in
breast lesions, particularly by discriminating microstructure
differences within the same lesion type. At present, larger
samples are being examined to clarify the role of DKI in
breast imaging.
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